Skip to main content

Table 1 Baseline characteristics

From: Pretransplant dyslipidaemia determines outcome in lung transplant recipients

  All Survivors Nonsurvivors P Without MCE with MCE P
  (n = 144) (n = 108) (n = 36)   (n = 134) (n = 10)  
Men/Women 84 (58.3%)/60 (41.7%) 66/42 25/11 0.56 81/53 7/3 0.78
Age → (yrs.) 44.8 ± 16.4 44.7 ± 16.5 49.9 ± 14.3 0.10 45.6 ± 16.1 50.9 ± 13.8 0.40
Weight (kg) 60.6 ± 16.6 58.9 ± 15.1 61.0 ± 14.2 0.81 59.6 ± 15.1 60.5 ± 13.9 0.69
Height (m) 1.67 ± 0.09 1.68 ± 0.09 1.71 ± 0.10 0.69 1.68 ± 0.09 1.71 ± 0.05 0.57
BMI (kg/m2) 21.6 ± 5.0 22.1 ± 4.2 23.5 ± 4.9 0.59 22.0 ± 4.9 22.9 ± 5.1 0.67
Creatinine (μmol/l) 75 ± 19 75 ± 18 76 ± 19 0.73 74 ± 19 87 ± 15 0.03
Urea (mmol/l) 4.4 ± 1.9 4.7 ± 1.8 4.9 ± 2.1 0.59 4.7 ± 1.8 5.4 ± 2.1 0.27
TC (mmol/l) 4.3 ± 1.6 4.2 ± 1.6 4.5 ± 1.5 0.33 4.2 ± 1.5 5.6 ± 2.0 0.007
Triglycerides (mmol/l) 1.2 ± 0.7 1.2 ± 0.7 1.3 ± 0.8 0.34 1.2 ± 0.7 1.0 ± 0.4 0.28
HDL (mmol/l) 1.5 ± 0.6 1.5 ± 0.6 1.5 ± 0.7 0.78 1.5 ± 0.6 1.9 ± 0.9 0.01
TC/HDL Ratio 3.0 ± 1.0 2.8 ± 0.7 3.6 ± 1.7 0.001 3.0 ± 1.1 2.2 ± 0.6 0.67
Underlying diseases        
CF 47 (32.6%) 40 7   46 1  
COPD 42 (29.2%) 30 12   37 5  
IPF 30 (20.8%) 20 10 0.19 28 2 0.67
PAH 9 (6.3%) 3 6   9 0  
Miscellaneous 16 (11.1%) 12 4   14 2  
  1. Data expressed as mean ± SD. Underlying diseases expressed as no. of patients and percentage of total no. of patients. BMI indicates body mass index, COPD chronic obstructive pulmonary disease, CF cystic fibrosis, HDL high-density lipoprotein, IPF idiopathic pulmonary fibrosis, PAH pulmonary arterial hypertension and TC total cholesterol. Paired T-test or chi-squared Test.